Ossiam’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.31M | Buy |
40,357
+18,528
| +85% | +$1.01M | 0.03% | 270 |
|
|
2026
Q1 | $1.23M | Buy |
21,829
+10,163
| +87% | +$593K | 0.02% | 204 |
|
|
2025
Q4 | $693K | Sell |
11,666
-5,791
| -33% | -$315K | 0.01% | 257 |
|
|
2025
Q3 | $945K | Buy |
17,457
+17,249
| +8,293% | +$986K | 0.01% | 484 |
|
|
2025
Q2 | $11.4K | Hold |
208
| – | – | ﹤0.01% | 624 |
|
|
2025
Q1 | $14.7K | Sell |
208
-268
| -56% | -$18K | ﹤0.01% | 599 |
|
|
2024
Q4 | $31.3K | Sell |
476
-2,369
| -83% | -$159K | ﹤0.01% | 590 |
|
|
2024
Q3 | $200K | Sell |
2,845
-121
| -4% | -$10.1K | ﹤0.01% | 538 |
|
|
2024
Q2 | $244K | Buy |
2,966
+5
| +0.2% | +$416 | ﹤0.01% | 524 |
|
|
2024
Q1 | $259K | Sell |
2,961
-1,704
| -37% | -$153K | ﹤0.01% | 555 |
|
|
2023
Q4 | $450K | Buy |
4,665
+1,946
| +72% | +$172K | 0.01% | 488 |
|
|
2023
Q3 | $241K | Sell |
2,719
-52
| -2% | -$4.63K | ﹤0.01% | 586 |
|
|
2023
Q2 | $240K | Buy |
2,771
+1,287
| +87% | +$121K | ﹤0.01% | 577 |
|
|
2023
Q1 | $144K | Sell |
1,484
-5,597
| -79% | -$580K | ﹤0.01% | 531 |
|
|
2022
Q4 | $733K | Buy |
7,081
+2,620
| +59% | +$246K | 0.02% | 314 |
|
|
2022
Q3 | $378K | Sell |
4,461
-1,302
| -23% | -$116K | 0.01% | 388 |
|
|
2022
Q2 | $478K | Buy |
5,763
+1,559
| +37% | +$124K | 0.01% | 317 |
|
|
2022
Q1 | $324K | Buy |
4,204
+1,866
| +80% | +$156K | 0.01% | 344 |
|
|
2021
Q4 | $207K | Sell |
2,338
-719
| -24% | -$59.3K | 0.01% | 365 |
|
|
2021
Q3 | $236K | Hold |
3,057
| – | – | 0.01% | 371 |
|
|
2021
Q2 | $235K | Buy |
3,057
+1,588
| +108% | +$126K | 0.01% | 371 |
|
|
2021
Q1 | $111K | Buy |
1,469
+726
| +98% | +$59.3K | ﹤0.01% | 381 |
|
|
2020
Q4 | $65K | Buy |
743
+624
| +524% | +$49.5K | ﹤0.01% | 376 |
|
|
2020
Q3 | $9K | Sell |
119
-2,016
| -94% | -$204K | ﹤0.01% | 385 |
|
|
2020
Q2 | $263K | Sell |
2,135
-9,493
| -82% | -$943K | 0.02% | 291 |
|
|
2020
Q1 | $983K | Buy |
11,628
+9,780
| +529% | +$843K | 0.07% | 176 |
|
|
2019
Q4 | $156K | Buy |
1,848
+1,626
| +732% | +$123K | 0.01% | 338 |
|
|
2019
Q3 | $15K | Sell |
222
-556
| -71% | -$42.8K | ﹤0.01% | 462 |
|
|
2019
Q2 | $67K | Buy |
+778
| New | +$66.6K | 0.01% | 399 |
|
Other funds holding BMRN
VPC
Ossiam's BMRN Position: Q2 2026 in Review
Ossiam increased its BioMarin Pharmaceuticals (BMRN) stake by 85% in Q2 2026, buying an estimated $1.01M and bringing the position to 40,357 shares worth $2.31M. The position accounts for 0.03% of the portfolio, ranked #270.
Ossiam first reported a position in BMRN in Q2 2019 and has held it in 29 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Ossiam held 40,357 shares of BioMarin Pharmaceuticals worth $2.31M as of Q2 2026.
- Ossiam bought 18,528 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $1.01M.
- BioMarin Pharmaceuticals made up 0.03% of Ossiam's portfolio in Q2 2026, its #270 holding.
- Ossiam first reported a position in BioMarin Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
- 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.